Edition:
India

Cumberland Pharmaceuticals Inc (CPIX.OQ)

CPIX.OQ on NASDAQ Stock Exchange Global Select Market

7.43USD
20 Nov 2017
Change (% chg)

-- (--)
Prev Close
$7.43
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,321
52-wk High
$7.95
52-wk Low
$5.30

Latest Key Developments (Source: Significant Developments)

Cumberland Pharmaceuticals Inc files for mixed shelf of up to $100 million
Wednesday, 8 Nov 2017 

Nov 7 (Reuters) - Cumberland Pharmaceuticals Inc ::Cumberland Pharmaceuticals Inc files for mixed shelf of up to $100 million .  Full Article

Cumberland Pharmaceutical reports Q3 loss per share $0.05
Wednesday, 8 Nov 2017 

Nov 7 (Reuters) - Cumberland Pharmaceuticals Inc :Cumberland Pharmaceutical reports 27% revenue growth in the third quarter.Q3 adjusted earnings per share $0.01.Q3 revenue rose 27 percent to $11.2 million.Q3 loss per share $0.05.  Full Article

Clinigen and Cumberland Pharmaceuticals launch dry mouth drug in U.S
Monday, 26 Sep 2016 

Clinigen Group Plc :Clinigen GrouE and Cumberland Pharmaceuticals launch Rthyol® in U.S.  Full Article

Cumberland Pharmaceuticals posts Q2 adj. earnings $0.04/shr
Wednesday, 3 Aug 2016 

Cumberland Pharmaceuticals Inc : Q2 adjusted earnings per share $0.04 . Q2 earnings per share $0.00 .Q2 revenue $7.4 million versus $8.9 million.  Full Article

Cumberland Pharmaceuticals Q1 adjusted earnings per share $0.02
Wednesday, 11 May 2016 

Cumberland Pharmaceuticals Inc : Cumberland Pharmaceuticals Inc says as of march 31, 2016, company had just under $90 million in total assets including over $51 million in cash and marketable securities . Cumberland Pharmaceuticals reports first quarter 2016 financial results . Q1 adjusted earnings per share $0.02 .Q1 revenue $7.7 million versus $8.7 million.  Full Article

Clinigen, Cumberland enter into U.S. commercialisation deal for ethyol
Tuesday, 10 May 2016 

Clinigen Group Plc :Co and Cumberland Pharmaceuticals enter into exclusive u.s. Commercialisation agreement for oncology support drug ethyol.  Full Article

BRIEF-Cumberland Pharmaceuticals Inc files for mixed shelf of up to $100 million

* Cumberland Pharmaceuticals Inc files for mixed shelf of up to $100 million Source text: (http://bit.ly/2jazuqV) Further company coverage: